Logo image of PGRE

PARAMOUNT GROUP INC (PGRE) Stock Fundamental Analysis

NYSE:PGRE - US69924R1086 - REIT

7.2 USD
+0.13 (+1.84%)
Last: 8/29/2025, 8:04:00 PM
7.05 USD
-0.15 (-2.08%)
After Hours: 8/29/2025, 8:04:00 PM
Fundamental Rating

3

PGRE gets a fundamental rating of 3 out of 10. The analysis compared the fundamentals against 129 industry peers in the Diversified REITs industry. While PGRE seems to be doing ok healthwise, there are quite some concerns on its profitability. PGRE is valued expensive and it does not seem to be growing.


Dividend Valuation Growth Profitability Health

2

1. Profitability

1.1 Basic Checks

In the past year PGRE has reported negative net income.
PGRE had a positive operating cash flow in the past year.
In the past 5 years PGRE always reported negative net income.
In the past 5 years PGRE always reported a positive cash flow from operatings.
PGRE Yearly Net Income VS EBIT VS OCF VS FCFPGRE Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200M -200M -400M

1.2 Ratios

The Return On Assets of PGRE (-0.98%) is worse than 67.44% of its industry peers.
PGRE has a worse Return On Equity (-2.58%) than 65.89% of its industry peers.
With a Return On Invested Capital value of 1.25%, PGRE is not doing good in the industry: 80.62% of the companies in the same industry are doing better.
PGRE had an Average Return On Invested Capital over the past 3 years of 1.50%. This is in line with the industry average of 3.06%.
Industry RankSector Rank
ROA -0.98%
ROE -2.58%
ROIC 1.25%
ROA(3y)-1.42%
ROA(5y)-0.96%
ROE(3y)-3.53%
ROE(5y)-2.37%
ROIC(3y)1.5%
ROIC(5y)1.5%
PGRE Yearly ROA, ROE, ROICPGRE Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 2 -2 -4 -6 -8

1.3 Margins

PGRE has a worse Operating Margin (16.70%) than 60.47% of its industry peers.
PGRE's Operating Margin has declined in the last couple of years.
Looking at the Gross Margin, with a value of 58.36%, PGRE is doing worse than 69.77% of the companies in the same industry.
In the last couple of years the Gross Margin of PGRE has remained more or less at the same level.
Industry RankSector Rank
OM 16.7%
PM (TTM) N/A
GM 58.36%
OM growth 3Y-5.7%
OM growth 5Y-3.09%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-1.88%
GM growth 5Y-1.42%
PGRE Yearly Profit, Operating, Gross MarginsPGRE Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 -20 40 60

5

2. Health

2.1 Basic Checks

PGRE has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
The number of shares outstanding for PGRE remains at a similar level compared to 1 year ago.
The number of shares outstanding for PGRE has been reduced compared to 5 years ago.
The debt/assets ratio for PGRE has been reduced compared to a year ago.
PGRE Yearly Shares OutstandingPGRE Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M 200M
PGRE Yearly Total Debt VS Total AssetsPGRE Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2B 4B 6B 8B

2.2 Solvency

Based on the Altman-Z score of 0.21, we must say that PGRE is in the distress zone and has some risk of bankruptcy.
The Altman-Z score of PGRE (0.21) is worse than 66.67% of its industry peers.
PGRE has a debt to FCF ratio of 47.15. This is a negative value and a sign of low solvency as PGRE would need 47.15 years to pay back of all of its debts.
PGRE's Debt to FCF ratio of 47.15 is fine compared to the rest of the industry. PGRE outperforms 62.02% of its industry peers.
A Debt/Equity ratio of 1.22 is on the high side and indicates that PGRE has dependencies on debt financing.
PGRE has a Debt to Equity ratio (1.22) which is in line with its industry peers.
Industry RankSector Rank
Debt/Equity 1.22
Debt/FCF 47.15
Altman-Z 0.21
ROIC/WACC0.19
WACC6.77%
PGRE Yearly LT Debt VS Equity VS FCFPGRE Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 1B 2B 3B 4B

2.3 Liquidity

PGRE has a Current Ratio of 4.01. This indicates that PGRE is financially healthy and has no problem in meeting its short term obligations.
The Current ratio of PGRE (4.01) is better than 93.80% of its industry peers.
PGRE has a Quick Ratio of 4.01. This indicates that PGRE is financially healthy and has no problem in meeting its short term obligations.
The Quick ratio of PGRE (4.01) is better than 93.80% of its industry peers.
Industry RankSector Rank
Current Ratio 4.01
Quick Ratio 4.01
PGRE Yearly Current Assets VS Current LiabilitesPGRE Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M 400M 500M

1

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 63.27% over the past year.
Looking at the last year, PGRE shows a decrease in Revenue. The Revenue has decreased by -1.68% in the last year.
The Revenue has been growing slightly by 0.36% on average over the past years.
EPS 1Y (TTM)63.27%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-125%
Revenue 1Y (TTM)-1.68%
Revenue growth 3Y1.39%
Revenue growth 5Y0.36%
Sales Q2Q%-5.53%

3.2 Future

PGRE is expected to show a very negative growth in Earnings Per Share. In the coming years, the EPS will decrease by -30.73% yearly.
PGRE is expected to show a decrease in Revenue. In the coming years, the Revenue will decrease by -3.52% yearly.
EPS Next Y-11.71%
EPS Next 2Y-44.52%
EPS Next 3Y-30.73%
EPS Next 5YN/A
Revenue Next Year-5.69%
Revenue Next 2Y-4.74%
Revenue Next 3Y-3.52%
Revenue Next 5YN/A

3.3 Evolution

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
PGRE Yearly Revenue VS EstimatesPGRE Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 200M 400M 600M
PGRE Yearly EPS VS EstimatesPGRE Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 0 -0.5 -1

2

4. Valuation

4.1 Price/Earnings Ratio

PGRE reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Also next year PGRE is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
PGRE Price Earnings VS Forward Price EarningsPGRE Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 50 100

4.2 Price Multiples

65.89% of the companies in the same industry are more expensive than PGRE, based on the Enterprise Value to EBITDA ratio.
PGRE's Price/Free Cash Flow ratio is a bit cheaper when compared to the industry. PGRE is cheaper than 76.74% of the companies in the same industry.
Industry RankSector Rank
P/FCF 20.33
EV/EBITDA 13.33
PGRE Per share dataPGRE EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 5 10

4.3 Compensation for Growth

PGRE's earnings are expected to decrease with -30.73% in the coming years. This may justify a cheaper valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-44.52%
EPS Next 3Y-30.73%

0

5. Dividend

5.1 Amount

PGRE does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

PARAMOUNT GROUP INC

NYSE:PGRE (8/29/2025, 8:04:00 PM)

After market: 7.05 -0.15 (-2.08%)

7.2

+0.13 (+1.84%)

Chartmill FA Rating
GICS SectorReal Estate
GICS IndustryGroupEquity Real Estate Investment Trusts (REITs)
GICS IndustryDiversified REITs
Earnings (Last)07-30 2025-07-30/amc
Earnings (Next)10-28 2025-10-28/amc
Inst Owners73.56%
Inst Owner Change0.98%
Ins Owners15.71%
Ins Owner Change0.39%
Market Cap1.59B
Analysts50.91
Price Target6.12 (-15%)
Short Float %3.83%
Short Ratio2.37
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly Dividend0.12
Dividend Growth(5Y)-23.74%
DP-10.73%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-77.7%
Min EPS beat(2)-145.1%
Max EPS beat(2)-10.29%
EPS beat(4)1
Avg EPS beat(4)-118.75%
Min EPS beat(4)-341.18%
Max EPS beat(4)21.57%
EPS beat(8)3
Avg EPS beat(8)-320.27%
EPS beat(12)5
Avg EPS beat(12)-259.31%
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)1
Avg Revenue beat(2)0.62%
Min Revenue beat(2)-0.23%
Max Revenue beat(2)1.47%
Revenue beat(4)2
Avg Revenue beat(4)1.41%
Min Revenue beat(4)-2.29%
Max Revenue beat(4)6.69%
Revenue beat(8)6
Avg Revenue beat(8)1.95%
Revenue beat(12)7
Avg Revenue beat(12)0.5%
Revenue beat(16)8
Avg Revenue beat(16)0.06%
PT rev (1m)10.34%
PT rev (3m)35.21%
EPS NQ rev (1m)-12.5%
EPS NQ rev (3m)40%
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)0.48%
Revenue NQ rev (3m)-2.99%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-0.24%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 2.13
P/FCF 20.33
P/OCF 7.73
P/B 0.52
P/tB 0.53
EV/EBITDA 13.33
EPS(TTM)-0.36
EYN/A
EPS(NY)-0.44
Fwd EYN/A
FCF(TTM)0.35
FCFY4.92%
OCF(TTM)0.93
OCFY12.93%
SpS3.38
BVpS13.74
TBVpS13.54
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -0.98%
ROE -2.58%
ROCE 1.59%
ROIC 1.25%
ROICexc 1.33%
ROICexgc 1.35%
OM 16.7%
PM (TTM) N/A
GM 58.36%
FCFM 10.47%
ROA(3y)-1.42%
ROA(5y)-0.96%
ROE(3y)-3.53%
ROE(5y)-2.37%
ROIC(3y)1.5%
ROIC(5y)1.5%
ROICexc(3y)1.58%
ROICexc(5y)1.58%
ROICexgc(3y)1.61%
ROICexgc(5y)1.61%
ROCE(3y)1.9%
ROCE(5y)1.89%
ROICexcg growth 3Y-2.68%
ROICexcg growth 5Y-0.82%
ROICexc growth 3Y-2.45%
ROICexc growth 5Y-0.45%
OM growth 3Y-5.7%
OM growth 5Y-3.09%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-1.88%
GM growth 5Y-1.42%
F-Score6
Asset Turnover0.09
Health
Industry RankSector Rank
Debt/Equity 1.22
Debt/FCF 47.15
Debt/EBITDA 10.22
Cap/Depr 53.93%
Cap/Sales 17.05%
Interest Coverage 250
Cash Conversion 56.97%
Profit Quality N/A
Current Ratio 4.01
Quick Ratio 4.01
Altman-Z 0.21
F-Score6
WACC6.77%
ROIC/WACC0.19
Cap/Depr(3y)48.92%
Cap/Depr(5y)46.58%
Cap/Sales(3y)15.71%
Cap/Sales(5y)15.02%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)63.27%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-125%
EPS Next Y-11.71%
EPS Next 2Y-44.52%
EPS Next 3Y-30.73%
EPS Next 5YN/A
Revenue 1Y (TTM)-1.68%
Revenue growth 3Y1.39%
Revenue growth 5Y0.36%
Sales Q2Q%-5.53%
Revenue Next Year-5.69%
Revenue Next 2Y-4.74%
Revenue Next 3Y-3.52%
Revenue Next 5YN/A
EBIT growth 1Y-12.95%
EBIT growth 3Y-4.39%
EBIT growth 5Y-2.74%
EBIT Next Year139.71%
EBIT Next 3Y25.08%
EBIT Next 5YN/A
FCF growth 1Y-40%
FCF growth 3Y3.52%
FCF growth 5Y-4.16%
OCF growth 1Y-19.1%
OCF growth 3Y2.74%
OCF growth 5Y-1.48%